LiveKarnataka Bank’s right issue has ended with over-subscription
The right issue of Karnataka Bank for one share for every two shares at Rs 70 apeice has closed with a subscription of over 185...
Category : Latest News
Practo has acquired Enlightiks Business in an all-cash, stock deal
Practo Technologies, a healthcare services start-up has acquired Enlightiks Business Solutions which is a healthcare analytics company, in an all cash and stock deal. Enlightiks...
Sumit Sehgal has been appointed by Intex as its CMO
Sumit Sehgal has been appointed by Intex Technology as its Chief Marketing Officer to lead brand transformation and conceptualise marketing initiatives across the various business...
Yes Bank partners with FortyTwo42 Labs to develop cyber security solutions
Yes bank has associated with FortyTwo42 Labs as a co-innovation partner for developing cyber security solutions. The bank has said in a statement that the...
Mercedes to increase prices from January
Mercedes-Benz, the German luxury carmaker has said that it will increase the prices of its entire model range in India, effective January 1, 2017, by...
Cipla’s Netherlands arm will invest up to euro 16.8 mn in Iranian JV
Cipla has said that its subsidiary in the Netherlands will be investing up to euro 16.8 million (nearly Rs 120 crore) to form a joint...
Patanjali has been fined with Rs 11 lakh for misleading ads
Patanjali Ayurved Ltd, Yoga guru Ramdev’s company has been fined with Rs 11 lakh by a city court on charges of misbranding and misrepresentation of...
Infosys has invested in ideaForge
Infosys, the country’s second largest software services firm has made investment in ideaForge which is an Indian startup that focuses on unmanned aerial vehicle or...
Paytm has partnered with NHAI for digital payments at toll plazas
Paytm has announced partnership with major NHAI toll concessionaries like Reliance Infra, Sadhbav, IRB, MEP, L&T and GMR for enabling cashless payments at all state,...
Lupin has received USFDA approval to market generic skin ointment
The US health regulator has provided its approval to Lupin for marketing its Desoximetasone ointment that are used in providing relief from inflammation and itching...